TY - JOUR
T1 - Cardiac biomarkers and acute kidney injury after cardiac surgery
AU - Bucholz, Emily M.
AU - Whitlock, Richard P.
AU - Zappitelli, Michael
AU - Devarajan, Prasad
AU - Eikelboom, John
AU - Garg, Amit X.
AU - Philbrook, Heather Thiessen
AU - Devereaux, Philip J.
AU - Krawczeski, Catherine D.
AU - Kavsak, Peter
AU - Shorttk, Colleen
AU - Parikh, Chirag R.
N1 - Publisher Copyright:
Copyright © 2015 by the American Academy of Pediatrics.
PY - 2015/4/1
Y1 - 2015/4/1
N2 - OBJECTIVES: To examine the relationship of cardiac biomarkers with postoperative acute kidney abstract injury (AKI) among pediatric patients undergoing cardiac surgery. METHODS: Data from TRIBE-AKI, a prospective study of children undergoing cardiac surgery, were used to examine the association of cardiac biomarkers (N-type pro-B-type natriuretic peptide, creatine kinase-MB [CK-MB], heart-type fatty acid binding protein [h-FABP], and troponins I and T) with the development of postoperative AKI. Cardiac biomarkers were collected before and 0 to 6 hours after surgery. AKI was defined as a ≥50% or 0.3 mg/dL increase in serum creatinine, within 7 days of surgery. RESULTS: Of the 106 patients included in this study, 55 (52%) developed AKI after cardiac surgery. Patients who developed AKI had higher median levels of pre- and postoperative cardiac biomarkers compared with patients without AKI (all P <.01). Preoperatively, higher levels of CK-MB and h-FABP were associated with increased odds of developing AKI (CK-MB: adjusted odds ratio 4.58, 95% confidence interval [CI] 1.56-13.41; h-FABP: adjusted odds ratio 2.76, 95% CI 1.27-6.03). When combined with clinical models, both preoperative CK-MB and h-FABP provided good discrimination (area under the curve 0.77, 95% CI 0.68-0.87, and 0.78, 95% CI 0.68-0.87, respectively) and improved reclassification indices. Cardiac biomarkers collected postoperatively did not significantly improve the prediction of AKI beyond clinical models. CONCLUSIONS: Preoperative CK-MB and h-FABP are associated with increased risk of postoperative AKI and provide good discrimination of patients who develop AKI. These biomarkers may be useful for risk stratifying patients undergoing cardiac surgery.
AB - OBJECTIVES: To examine the relationship of cardiac biomarkers with postoperative acute kidney abstract injury (AKI) among pediatric patients undergoing cardiac surgery. METHODS: Data from TRIBE-AKI, a prospective study of children undergoing cardiac surgery, were used to examine the association of cardiac biomarkers (N-type pro-B-type natriuretic peptide, creatine kinase-MB [CK-MB], heart-type fatty acid binding protein [h-FABP], and troponins I and T) with the development of postoperative AKI. Cardiac biomarkers were collected before and 0 to 6 hours after surgery. AKI was defined as a ≥50% or 0.3 mg/dL increase in serum creatinine, within 7 days of surgery. RESULTS: Of the 106 patients included in this study, 55 (52%) developed AKI after cardiac surgery. Patients who developed AKI had higher median levels of pre- and postoperative cardiac biomarkers compared with patients without AKI (all P <.01). Preoperatively, higher levels of CK-MB and h-FABP were associated with increased odds of developing AKI (CK-MB: adjusted odds ratio 4.58, 95% confidence interval [CI] 1.56-13.41; h-FABP: adjusted odds ratio 2.76, 95% CI 1.27-6.03). When combined with clinical models, both preoperative CK-MB and h-FABP provided good discrimination (area under the curve 0.77, 95% CI 0.68-0.87, and 0.78, 95% CI 0.68-0.87, respectively) and improved reclassification indices. Cardiac biomarkers collected postoperatively did not significantly improve the prediction of AKI beyond clinical models. CONCLUSIONS: Preoperative CK-MB and h-FABP are associated with increased risk of postoperative AKI and provide good discrimination of patients who develop AKI. These biomarkers may be useful for risk stratifying patients undergoing cardiac surgery.
UR - http://www.scopus.com/inward/record.url?scp=84927772497&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84927772497&partnerID=8YFLogxK
U2 - 10.1542/peds.2014-2949
DO - 10.1542/peds.2014-2949
M3 - Article
C2 - 25755241
AN - SCOPUS:84927772497
SN - 0031-4005
VL - 135
SP - e945-e956
JO - Pediatrics
JF - Pediatrics
IS - 4
ER -